SEARCH
Enter your search term below:
Close
Enter your search term below:
WORLD LEADING BUSINESS SUPPORT
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close
If you run a business in #Swindon & #Wiltshire & want to find out how our fully-funded support can help you grow &… twitter.com/i/web/status/15414…
Got an idea for a #healthtech product or service? We're running the fully-funded #HealthInnovationProgramme with… twitter.com/i/web/status/15414…
It's a wrap! 5 days of intense workshops and training completed by these amazing clinical entrepreneurs for the… twitter.com/i/web/status/15414…
Not long to go until @SETsquared_Br's Tech-Xpo 2022! We can't wait to see 16 innovators exhibit & demo their busin… twitter.com/i/web/status/15413…
SETsquared hosted an investment panel discussion for @ShineInnovate LIF Global Programme participants with experts… twitter.com/i/web/status/15403…
SETsquared is a partnership between